Prospective, open, multicentre, non-interventional Study in adult Patients with Asthma or COPD to Assess the clinical Effectiveness of the Salmeterol/Fluticasone Easyhaler in daily Practice

被引:0
|
作者
Hennig, Rudolf [1 ]
Vinge, Ines [2 ]
Syk, Joergen [3 ]
Xanthopoulos, Athanasios
Lassmann, Hendrik
Vahteristo, Mikko [4 ]
Sairanen, Ulla [4 ]
Lahelma, Satu [4 ]
Mueler, Matthias
机构
[1] Lungenarzte Radebeul Gemeinschaftspraxis, Radebeul, Germany
[2] Fys Med & Stockholm AB, Lindingo, Sweden
[3] Acad Primary Hlth Care Ctr, Stockholm, Sweden
[4] Orion Corp, Espoo, Finland
来源
INTERNIST | 2021年 / 62卷 / SUPPL 2期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
WB56
引用
收藏
页码:178 / 178
页数:1
相关论文
共 50 条
  • [11] The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice
    Doniec, Zbigniew
    Olszanecka-Glinianowicz, Magdalena
    Hantulik, Piotr
    Almgren-Rachtan, Agnieszka
    Chudek, Jerzy
    JOURNAL OF ASTHMA, 2023, 60 (04) : 754 - 760
  • [12] A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE)
    Lixin Guo
    Jing Wang
    Li Li
    Lin Yuan
    Sheng Chen
    Hui Wang
    Tonghuan Li
    Lin Qi
    Hong Yang
    BMC Medicine, 21
  • [13] A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE)
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    BMC MEDICINE, 2023, 21 (01)
  • [14] ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany
    Iking-Konert, Christof
    von Hinueber, Ulrich
    Richter, Constanze
    Schwenke, Holger
    Guertler, Irmgard
    Kaestner, Peter
    Klapperich, Birgit
    Peters, Marvin A.
    Burmester, Gerd-Ruediger
    RHEUMATOLOGY, 2016, 55 (04) : 624 - 635
  • [15] Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management
    Backer, Vibeke
    Ellery, Adam
    Borzova, Sylvia
    Lane, Stephen
    Kleiberova, Magda
    Bengtsson, Peter
    Tomala, Tadeusz
    Basset-Stheme, Dominique
    Bennett, Carla
    Lindner, Dirk
    Meiners, Arthur
    Overend, Tim
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [16] Open label, multicenter, prospective non-interventional study to monitor the safety and effectiveness of Bevacizumab with chemotherapy in patients with NSCLC under conditions of routine clinical practice in Germany
    Tessen, H. W.
    Linck, D.
    Losem, C.
    Gessner, C.
    Metze, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S637 - S637
  • [17] PROPORTION AND CLINICAL CHARACTERISTICS OF ASTHMA-COPD OVERLAP (ACO) IN CHINA: A NON-INTERVENTIONAL STUDY
    Kang, Jian
    Zheng, Jinping
    Cai, Baiqiang
    Wen, Fuqiang
    Yao, Wanzhen
    Zhang, Xiaoju
    Chen, Yan
    Wang, Guansong
    Li, Wen
    Cao, Jie
    Ling, Xia
    Shang, Hongyan
    RESPIROLOGY, 2017, 22 : 229 - 229
  • [18] Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
    Blockeel, Christophe
    Griesinger, Georg
    Rago, Rocco
    Larsson, Per
    Sonderegger, Yum Lina Yip
    Riviere, Stephane
    Laven, Joop S. E.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [19] Elderly patients treated with afatinib in clinical practice: Results from the prospective non-interventional study GIDEON
    Brueckl, W.
    Laack, E.
    Kortsik, C.
    Schaefer, H.
    Reck, M.
    Maerten, A.
    Hoffmann, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [20] A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients
    Ulf W Tunn
    BMC Urology, 11